These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15621081)

  • 1. Update on liver transplantation using cyclosporine.
    Schrem H; Lück R; Becker T; Nashan B; Klempnauer J
    Transplant Proc; 2004 Nov; 36(9):2525-31. PubMed ID: 15621081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine.
    Furukawa H; Todo S
    Transplant Proc; 2004 Mar; 36(2 Suppl):274S-284S. PubMed ID: 15041353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac transplant experience with cyclosporine.
    Patel JK; Kobashigawa JA
    Transplant Proc; 2004 Mar; 36(2 Suppl):323S-330S. PubMed ID: 15041362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cyclosporine on the development of immunosuppressive therapy.
    Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2004 Mar; 36(2 Suppl):130S-134S. PubMed ID: 15041322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoral therapy in liver transplantation.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2225-8. PubMed ID: 8769206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with cyclosporine in the Canary Islands.
    Hernández D
    Transplant Proc; 2004 Mar; 36(2 Suppl):120S-124S. PubMed ID: 15041320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of cyclosporine for liver transplantation.
    Lilly LB; Grant D
    Transplant Proc; 2004 Mar; 36(2 Suppl):267S-270S. PubMed ID: 15041351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cyclosporine in renal transplantation.
    Kyriakides G; Miller J
    Transplant Proc; 2004 Mar; 36(2 Suppl):167S-172S. PubMed ID: 15041330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoral/cyclosporine-based immunosuppression.
    Levy GA
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S37-47. PubMed ID: 10431016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
    Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
    Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with cyclosporine: from revolution to evolution of immunosuppressive protocols in thoracic organ transplantation.
    Haverich A; Gorler H
    Transplant Proc; 2004 Mar; 36(2 Suppl):314S-317S. PubMed ID: 15041360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
    Burdelski MM
    Transplant Proc; 2004 Mar; 36(2 Suppl):295S-298S. PubMed ID: 15041356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
    J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation 1994: the year in review.
    Browne BJ; Kahan BD
    Clin Transpl; 1994; ():317-40. PubMed ID: 7547552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.